TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
KLRS

Kalaris Therapeutics, Inc.

Healthcare · Biotechnology

3.10$ -3.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement KLRS
Line item 2018 2019 2020 2021 2022 2023 2024 2025
0.40 0.06 – – 0.00 0.00 0.00 0.00
– – 0.06 0.41 – – – 0.00
– – -0.06 -0.41 – – – 0.00
0.60 5.73 42.40 43.82 3.53 2.59 2.46 2.01
– – – – 0.67 0.39 1.34 1.01
1.67 9.48 60.91 61.80 4.20 2.98 11.03 3.02
-1.27 -9.43 -60.98 -62.21 -4.20 -2.98 -11.03 -3.02
– – – – 0.07 0.15 0.54 0.09
-0.86 -8.42 -59.67 -62.63 -4.65 -3.25 -11.73 -2.85
– – – 0.37 – – – –
-0.86 -8.42 -59.67 -63.00 -4.65 -3.25 -11.73 -2.85
-0.86 -8.41 -59.61 -62.22 -4.58 -3.10 -11.73 -2.75

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?